Vergoeding 2019-2023 voor ATC-subgroep L04AG08 : Ocrelizumab
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022* | 2023* | |
|---|---|---|---|---|---|
|
L04AG08 Ocrelizumab
|
26.612.661 | 31.722.793 | 45.874.148 | 60.735.720 | 73.199.837 |
| Totaal | 26.612.661 | 31.722.793 | 45.874.148 | 60.735.720 | 73.199.837 |